ORGO
Organogenesis Holdings Inc - Ordinary Shares - Class A

3,148
Loading...
Loading...
News
all
press releases
MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending
Investing.com -- MiMedx Group (NASDAQ:MDXG) stock fell 19% and Organogenesis Holdings (NASDAQ:ORGO) shares plunged 36% after the Centers for Medicare&Medicaid Services (CMS) proposed a rule that would drastically cut Medicare spending on skin substitutes.
investing.com·3mo ago
News Placeholder
More News
News Placeholder
Organogenesis (ORGO) Reports Q1 Loss, Lags Revenue Estimates
chainwire·5mo ago
News Placeholder
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Globe Newswire·2y ago
News Placeholder
Palumbo Wealth Management LLC Buys New Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Palumbo Wealth Management LLC bought a new stake in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and...
Ticker Report·2y ago
News Placeholder
Organogenesis Holdings Inc. (NASDAQ:ORGO) to Post FY2024 Earnings of $0.00 Per Share, Cantor Fitzgerald Forecasts
Organogenesis Holdings Inc. (NASDAQ:ORGO Free Report) Investment analysts at Cantor Fitzgerald reduced their FY2024 earnings estimates for Organogenesis in a research report issued...
Zolmax·2y ago
News Placeholder
Swiss National Bank Invests $505,000 in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Swiss National Bank bought a new position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO Free Report) during the 3rd quarter, according to its most recent 13F filing with the...
Zolmax·2y ago
News Placeholder
Q4 2023 Organogenesis Holdings Inc Earnings Call Transcript
Related Stocks: NAS:ORGO...
GuruFocus·2y ago
News Placeholder
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Globe Newswire·2y ago
News Placeholder
Organogenesis Holdings Q4 2023 Earnings Preview
Organogenesis Holdings Q4 2023 Earnings Preview...
SeekingAlpha.com: All News·2y ago
News Placeholder
Organogenesis Holdings (ORGO, $3.58) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 27, 2024
This is a Bullish indicator signaling ORGO's price could rise from here. Traders may explore going long the stock or buying call options...
Tickeron - Stocks·2y ago

Latest ORGO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.